USANA Health Sciences, Inc. (USNA) Stock Score, Valuation & Financial Research
USANA Health Sciences, Inc. is in the Consumer Defensive sector and Packaged Foods industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 37/100.
Quick answer for USNA
USANA Health Sciences, Inc. currently has a Wall Street Score of 37/100. The stored market price is $15.02. Its financial score is 26/100. Its valuation score is 16/100. These figures are a research snapshot, not a buy or sell recommendation.
What USANA Health Sciences, Inc. does
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The compa
USNA financial snapshot
- Wall Street Score:
- 37/100
- Current price:
- $15.02
- Market capitalization:
- $277.3M
- Revenue:
- $925.9M
- Net income:
- $8.9M
- Free cash flow:
- $8.5M
- Cash:
- $162.8M
- Total debt:
- $14.0M
- EPS:
- 0.58
- P/E ratio:
- 25.9x
- Financial score:
- 26/100
- Valuation score:
- 16/100
- Revenue score:
- 23/100
What stands out
- Reported year-over-year revenue growth is +0.0%.
- Free cash flow is $8.5M, showing positive cash generation.
- The balance sheet shows $162.8M of cash versus $14.0M of total debt, leaving more cash than debt.
What the numbers mean
Its current valuation score is 16/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 26/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-07-24.
How to research USNA
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.